- Home
- TCBP vs SHPH Comparison
TCBP vs SHPH Comparison
Compare TCBP & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBP
- SHPH
- Stock Information
- Founded
- TCBP 2013
- SHPH 2012
- Country
- TCBP United Kingdom
- SHPH United States
- Employees
- TCBP N/A
- SHPH N/A
- Industry
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- TCBP Health Care
- SHPH Health Care
- Exchange
- TCBP Nasdaq
- SHPH Nasdaq
- Market Cap
- TCBP 3.0M
- SHPH 2.7M
- IPO Year
- TCBP 2022
- SHPH 2022
- Fundamental
- Price
- TCBP $0.65
- SHPH $0.64
- Analyst Decision
- TCBP Strong Buy
- SHPH
- Analyst Count
- TCBP 1
- SHPH 0
- Target Price
- TCBP $3.00
- SHPH N/A
- AVG Volume (30 Days)
- TCBP 814.6K
- SHPH 73.1K
- Earning Date
- TCBP 02-09-2025
- SHPH 11-13-2024
- Dividend Yield
- TCBP N/A
- SHPH N/A
- EPS Growth
- TCBP N/A
- SHPH N/A
- EPS
- TCBP N/A
- SHPH N/A
- Revenue
- TCBP N/A
- SHPH N/A
- Revenue This Year
- TCBP N/A
- SHPH N/A
- Revenue Next Year
- TCBP N/A
- SHPH N/A
- P/E Ratio
- TCBP N/A
- SHPH N/A
- Revenue Growth
- TCBP N/A
- SHPH N/A
- 52 Week Low
- TCBP $0.44
- SHPH $0.61
- 52 Week High
- TCBP $41.50
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- TCBP 36.84
- SHPH 27.09
- Support Level
- TCBP $0.45
- SHPH $0.61
- Resistance Level
- TCBP $0.70
- SHPH $0.79
- Average True Range (ATR)
- TCBP 0.08
- SHPH 0.06
- MACD
- TCBP 0.10
- SHPH 0.00
- Stochastic Oscillator
- TCBP 55.58
- SHPH 12.15
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.